Stay updated on SAGE-217 Pharmacodynamic in Insomnia Model Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 Pharmacodynamic in Insomnia Model Clinical Trial page.

Latest updates to the SAGE-217 Pharmacodynamic in Insomnia Model Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded New York as a study location under Locations and updated the page revision to v3.3.3. Removed the New York Locations label and the HHS Vulnerability Disclosure link in the footer.SummaryDifference0.3%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now shows Revision: v3.3.2 instead of Revision: v3.2.0. This update appears to be an internal version change and does not modify the study content or data.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the site-wide notice about a lapse in government funding and NIH operating status; this change does not affect the study details or eligibility information shown — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedThe sponsor changed from Sage Therapeutics to Biogen. Biogen is now listed as sponsor and responsible party on the study page.SummaryDifference0.5%

- Check91 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference6%

- Check98 days agoChange Detected- Added Revision: v3.1.0. - Removed topics: MedlinePlus related topics: Drug Safety; Counterfeit Drugs; Pharmaceutical Preparations; Substandard Drugs; Revision: v3.0.2.SummaryDifference1.0%

Stay in the know with updates to SAGE-217 Pharmacodynamic in Insomnia Model Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 Pharmacodynamic in Insomnia Model Clinical Trial page.